TransEnterix 2018 Q1 revenue reaches $4.8M, new loss totals $11.3M: 5 details

Written by Mackenzie Garrity | May 09, 2018 | Print  |

TransEnterix released its first quarter 2018 financial results.

Here are five details.

1. For the quarter, TransEnterix reported $4.8 million in revenues compared to $1.9 million in revenue during the same period of 2017.

2. The company's total net operating income and expenses were $5.4 million. In the first quarter of 2017, TransEnterix reported $16.5 million in total net operating income and expenses.

3. TransEnterix's net loss in the first quarter was $900,000, as compared to $15.4 million in the same quarter of 2017.

4. Adjusted net loss in the first quarter topped $11.3 million or $0.06 per share. In the first quarter of 2017, the company's adjusted new loss was $12.6 million or $0.11 per share.

5. TransEnterix sold two Senhance Systems in the first quarter, totally $3.5 million in sales. The company also filed an FDA submission to expand the use of the minimally invasive surgery system.

More articles on MIS:
University of Pennsylvania surgeons perform 1st-of-its-kind robotic spine surgery: 7 things to know
Medtronic launches new system for minimally invasive spine surgery: 5 things to know
NASS publishes positive coverage guidance for lumbar interspinous devices without fusion but with decompression

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months